References
- Kasiske BL. Epidemiology of cardiovascular disease after
renal transplantation. Transplantation. 2001; 72 (6): S5- S8. PubMed | Google
Scholar
- Haute Autorité de Santé communication Service. Recommandations
professionelles de l’AFSAAPS : Suivi ambulatoire de l’adulte transplanté rénal
au delà de 03 mois après transplatation rénale. Novembre 2007. France.Haute
Autorité de Santé communication Service.
- Bittar AE, Ratcliffe PJ, Richardson AJ, et al. The
prevalence of hyperlipidemia in renal transplant recipients: Association
with immunosuppressive and antihypertensive therapy. Transplantation.
1990;50(6): 987-992. PubMed | Google
Scholar
- Kartnelson S, Wilkinson AH, Kobashigawa JA, et al.
The effect of pravastatin on acute rejection after kidney transplantation:
A pilot study. Transplantation. 1996 ; 61(10): 1469-1474. PubMed | Google
Scholar
- Cosio FG, Pesavento TE, Kim S, Osei K, et al.
Patient survival after renal transplantation: Impact
of post-transplant diabetes. Kidney Int. 2002;
62 (4):1440-1446. PubMed | Google
Scholar
- Pescovitz MD, Govani M. Sirolimus and mycophenolate mofetil for calcineurin-free immunosuppression in renal transplant recipients. Am J Kidney Dis. 2001;38(suppl2): S16-21. PubMed | Google Scholar
- Davidson J, Wilkinson A, Dantal J, Dotta F,
Haller H et al.., New-onset diabetes
after transplantation: 2003 international consensus
guidelines, Transplantation. 2003;75 (suppl10):
S3-S24. PubMed | Google
Scholar
- Heisel O, Heisel R, Balshaw R, Keown P. New
onset diabetes mellitus in patients receiving calcineurin
inhibitors: a systematic review and meta-analysis.
Am J Transplant. 2004;4(4):583-595. PubMed | Google
Scholar
- Clive DM. Renal transplant-associated hyperuricemia and gout. J Am Soc Nephrol. 2000 ; 11(5): 974-9. PubMed | Google Scholar
- Wortmann RL. Gout and hyperuricemia. Curr Opin Rheumatol. 2002 ; 14(3): 281-6.. PubMed | Google Scholar
- Jindal RM, Zawada Jr. ET. Obesity and kidney transplantation. Am J Kidney Dis. 2004;43(6):943–52. PubMed | Google Scholar